Sana Biotechnology, Inc. - SANA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Fund IX, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Fund IX Overage, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Fund X, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Fund X Overage, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners IX, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners IX Overage, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners X Overage, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners X, L.P. 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners IX, LLC 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A ARCH Venture Partners X, LLC 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A Keith Crandell 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A Clinton Bybee 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A Robert Nelsen 15.4% 46,173,125 View
Aug 14, 2026 SCHEDULE 13G/A Steven Gillis 15.3% 45,860,681 View
Aug 14, 2026 SCHEDULE 13G/A Kristina Burow 15.3% 45,860,681 View
May 21, 2026 SCHEDULE 13G RA Capital Management, L.P. 6.3% 18,750,000 View
May 21, 2026 SCHEDULE 13G Peter Kolchinsky 6.3% 18,750,000 View
May 21, 2026 SCHEDULE 13G Rajeev Shah 6.3% 18,750,000 View
May 21, 2026 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 6.3% 18,750,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.